Novo Medi Sciences

Novo Medi Sciences is an Indian specialty pharmaceutical company focused on manufacturing, marketing, and distribution of vaccines, critical care products, and other hospital- and specialty-care medicines. The company presents itself as part of the Novo Group, tracing its operating heritage to 1946, while the current private limited entity appears to have been incorporated in 2013. Its portfolio spans pediatric care, critical care, institution business, and international business, with a strong emphasis on affordable vaccines and injectable products. Novo Medi Sciences is best known for its varicella vaccine franchise, including Nexipox and the more recently launched NEXIPOX PLUS. The company also markets products across cardiovascular, immunology, oncology, fertility, neurology, antibiotics, and blood-product related segments in India. Overall, it appears to be a commercial-stage private pharmaceutical manufacturer and marketer rather than a venture-stage biotech focused on novel clinical pipelines.